Results 241 to 250 of about 1,097,318 (312)
Objective Social determinants of health (SDoH) can impact outcomes but are not routinely screened for in US outpatient rheumatology clinics. This study determined the feasibility of routine point‐of‐care SDoH screening among patients with systemic lupus erythematosus (SLE) and associated barriers and facilitators at the physician, care team, and ...
S. Sam Lim+11 more
wiley +1 more source
Cannabinoids and the endocannabinoid system in liver diseases. [PDF]
Parfieniuk-Kowerda A+4 more
europepmc +1 more source
Objective We assessed whether shared decision‐making (SDM), and patient acceptability, feasibility, and overall satisfaction with a computerized patient decision aid (PtDA) for patients with systemic lupus erythematosus (SLE), differs by PtDA setting, modality, and the viewing experience.
Jasvinder A. Singh+3 more
wiley +1 more source
Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China. [PDF]
Chen J, Zhang S, Cao X, Daer D, Lin B.
europepmc +1 more source
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim+18 more
wiley +1 more source
Predictors for psychosocial consequences of screening for liver diseases: A data-driven approach. [PDF]
Fichtner UA, Maun A, Farin-Glattacker E.
europepmc +1 more source
Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli+8 more
wiley +1 more source
Lactate and lactylation in liver diseases: energy metabolism, inflammatory immunity and tumor microenvironment. [PDF]
Cheng S, Xiao X, Wang D, Wang X, Yang M.
europepmc +1 more source